axonmedchem/天然干细胞5i抑制剂组/每个2 mg/Axon 5011

价格
¥4000.00
货号:Axon5011
浏览量:127
品牌:axonmedchem
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Naive Stem Cell 5i inhibitor Set

Based on 14 reference(s) in Google Scholar101014

Axon 5011

CAS [N.A.]

MF #N/AMW #N/A

  • Purity:99%
  • Soluble in DMSO

Naive Stem Cell 5i inhibitor Set

Description

A convenient set of five small molecule pathway inhibitors (termed as Naive stem cell 5i inhibitors): - BRAF inhibitor SB 590885 (Axon 2504) - MEK inhibitor PD 0325901 (Axon 1408) - ROCK inhibitor Y 27632 dihydrochloride (Axon 1683) - SRC/LCK inhibitor WH 4-023 (Axon 2381) - GSK3β inhibitor IM-12 (Axon 2511).(*Alternatively, CHIR99021 (Axon 1386) can be used as GSK3β inhibitor. Not included.) The combination of five inhibitors of MEK, GSK3β, BRAF, ROCK, and SRC, supports the expansion of viable OCT4-ΔPE-GFP+ human pluripotent cells after exogenous transcription factor expression has been removed. Useful tool for the induction and maintenance of human naive stem cell pluripotency.

Read more: Additional Product Information

Show allAxon Ligand™Sets

KEYWORDS: Naive Stem Cell 5i inhibitor Set | supplier | Stem cell inhibitor set | SB 590885 | PD 0325901 | Y 27632 | WH-4-023 | IM 12 | CAS [405554-55-4] | [391210-10-9] | [129830-38-2] | [837422-57-8] | [1129669-05-1] | Inhibitor | Axon Ligand Sets | BRAF | MEK | ROCK | Src | Lck | GSK3β | naive | expansion | OCT4-ΔPE-GFP+ | pluripotent | hPCs | transcription factor | induction | human | stem cell | hPSC | pluripotency

TW Theunissen et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell. 2014 Oct 2;15(4):471-87.

List of publications using PD 0325901 (Axon 1408) purchased from Axon Medchem

List of publications using Y 27632 dihydrochloride (Axon 1683) purchased from Axon Medchem

  • Certificate of Analysis
  • Material Safety Data Sheet
  • Additional Product Information
Cell Signaling & OncologyCNSDiabetes & MetabolismImmunologyPain & InflammationStem CellGSK-3SRCROCKLckWnt-β-CateninPI3K-Akt-mTORStem CellsMEKRAF
Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency

Chemical name

N.A.

Parent CAS No.

[N.A.]

Axon Medchem是从Axon Biochemicals BV衍生出来的欧洲领先的药物化学服务平台。 它与Axon Biochemicals BV一起,作为药物化学的合同研究组织(CRO)进行业务运营。在2006年进行分拆之后,Axon Medchem已发展成为高价值生命科学产品的主要来源,将Axon Ligands™作为全球公认的药物标准用于药物研究。因此,我们的目标是与相关的科学出版物保持同步,以便为潜在客户提供开发针对已知疾病和病理学的新型疗法的最新进展,这些疾病包括诸如精神疾病,肿瘤,阿尔茨海默氏症和帕金森氏病,糖尿病,炎性疾病等。虽然我们提供的大多数产品都是由受过良好教育的熟练化学药剂师内部合成的,但有些是由研究合作伙伴提供的。尽管如此,所有Axon Ligands™均符合高质量的控制标准,这些标准可确保在全球竞争对手中保证最佳的产品质量,这显然受到了国际客户的赞赏。除了Axon Ligands™的零售外,Axon Medchem还专门从事合同研究以及在合同研究的基础上高质量合成生物活性和/或类药物分子。该公司旨在根据需要为制药,(生物)化学,农业和/或生物技术公司以及全球研究机构提供专门的化学服务。药物设计与合成,潜在客户开发以及结构活性关系(SAR)阐明;我们积累了有关前线药物化学研究的基本知识,可以满足所有客户的需求。